Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Antibodies"" wg kryterium: Temat


Tytuł :
Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections.
Autorzy :
Lai R; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhou T; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xiang X; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lu J; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Xin H; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Xie Q; Department of Infectious Diseases, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. .
Pokaż więcej
Źródło :
Frontiers of medicine [Front Med] 2021 Aug; Vol. 15 (4), pp. 644-648. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Letter
MeSH Terms :
Antibodies, Monoclonal*/therapeutic use
COVID-19*
Antibodies, Neutralizing ; Antibodies, Viral ; Humans ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus
Opinia redakcyjna
Tytuł :
Correspondence on 'Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.
Autorzy :
Salviani C; Nephrology Unit, ASST Spedali Civili di Brescia, Brescia, Italy .
Scolari F; Nephrology Unit, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Medical and Surgical Specialties, University of Brescia, Brescia, Italy.
Alberici F; Nephrology Unit, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Medical and Surgical Specialties, University of Brescia, Brescia, Italy.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Oct; Vol. 80 (10), pp. e158. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Letter; Comment
MeSH Terms :
Antibodies, Neutralizing*
COVID-19 Vaccines*
Antibodies, Viral ; Humans ; Immunosuppression ; RNA, Messenger
Opinia redakcyjna
Tytuł :
Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection.
Autorzy :
Wisnivesky JP; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. .; Division Pulmonary and Critical Care Medicine, Icahn School of Medicine at Mount Sinai, NY, New York, USA. .
Stone K; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
Bagiella E; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Doernberg M; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
Mendu DR; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Lin JJ; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
Kale M; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
Pokaż więcej
Źródło :
Journal of general internal medicine [J Gen Intern Med] 2021 Oct; Vol. 36 (10), pp. 3289-3291. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji :
Letter
MeSH Terms :
Antibodies, Neutralizing*
COVID-19*
Antibodies, Viral ; Humans ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
[Development of a blocking ELISA based on a single-domain antibody target the S1 protein of porcine epidemic diarrhea virus].
Autorzy :
Ma Z; College of Veterinary Medicine, Northwest Agricultural and Forestry University, Yangling 712100, Shaanxi, China.
Bai G; Weinan Animal Disease Control Center, Weinan 714000, Shaanxi, China.
Wang T; College of Veterinary Medicine, Northwest Agricultural and Forestry University, Yangling 712100, Shaanxi, China.
Li Z; College of Veterinary Medicine, Northwest Agricultural and Forestry University, Yangling 712100, Shaanxi, China.
Li Y; College of Veterinary Medicine, Northwest Agricultural and Forestry University, Yangling 712100, Shaanxi, China.
Xiao S; College of Veterinary Medicine, Northwest Agricultural and Forestry University, Yangling 712100, Shaanxi, China.
Li S; College of Veterinary Medicine, Northwest Agricultural and Forestry University, Yangling 712100, Shaanxi, China.
Pokaż więcej
Źródło :
Sheng wu gong cheng xue bao = Chinese journal of biotechnology [Sheng Wu Gong Cheng Xue Bao] 2021 Sep 25; Vol. 37 (9), pp. 3221-3230.
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus Infections*/veterinary
Porcine epidemic diarrhea virus*/genetics
Single-Domain Antibodies*
Swine Diseases*
Animals ; Antibodies, Viral ; Enzyme-Linked Immunosorbent Assay ; Reproducibility of Results ; Sensitivity and Specificity ; Swine
Czasopismo naukowe
Tytuł :
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.
Autorzy :
Law JLM; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada. Electronic address: .
Logan M; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Joyce MA; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Landi A; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Hockman D; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Crawford K; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Johnson J; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
LaChance G; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Saffran HA; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Shields J; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Hobart E; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Brassard R; Department of Biochemistry, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Arutyunova E; Department of Biochemistry, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Pabbaraju K; Alberta Precision Laboratories, Edmonton, Canada.
Croxen M; Alberta Precision Laboratories, Edmonton, Canada.
Tipples G; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada; Alberta Precision Laboratories, Edmonton, Canada.
Lemieux MJ; Department of Biochemistry, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Tyrrell DL; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.
Houghton M; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Sep 24; Vol. 39 (40), pp. 5769-5779. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing*
COVID-19*
Antibodies, Viral ; Humans ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/genetics
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
Autorzy :
Choe PG; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kang CK; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim KH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.
Yi J; Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.
Kim ES; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Park SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim NJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Park WB; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Oh MD; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Sep 17; Vol. 224 (6), pp. 1097-1099.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Antibodies, Neutralizing*
COVID-19*
Antibodies, Viral ; Antibody Formation ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
Autorzy :
Taylor SC; GENSCRIPT USA INC., 860 Centennial Ave., Piscataway, NJ 08854, USA. Electronic address: .
Hurst B; Cayman Chemical, 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA.
Martiszus I; Cure-Hub, 12655 SW Beaverdam Rd., Beaverton, OR 97005, USA.
Hausman MS; FourthWall Testing LLC, 455 9th Street Suite 128, Winter Garden, FL 34787, USA.
Sarwat S; DYNEX Technologies, 14340 Sullyfield Circle, Chantilly, VA 20151-1621, USA.
Schapiro JM; Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.
Rowell S; Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.
Lituev A; Kaiser Permanente, 1795 A Second Street, Berkeley, CA 94710, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Sep 15; Vol. 39 (39), pp. 5688-5698. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing*
COVID-19*
Antibodies, Viral ; Humans ; Immunity ; Neutralization Tests ; SARS-CoV-2 ; Seroepidemiologic Studies ; Vaccination
Czasopismo naukowe
Tytuł :
Illuminating the Fc dependence of SARS-CoV-2 neutralization.
Autorzy :
González JC; Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA; Immunology Interdepartmental Program, Stanford University, Stanford, CA, USA.
Wang TT; Department of Medicine, Division of Infectious Diseases, Stanford University, Stanford, CA, USA; Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA; Chan Zuckerberg Biohub, San Francisco, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Immunity [Immunity] 2021 Sep 14; Vol. 54 (9), pp. 1912-1914. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Antibodies, Neutralizing*
COVID-19*
Animals ; Antibodies, Viral ; Humans ; Mice ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus
Czasopismo naukowe
Tytuł :
[The relationship between elevated antiphospholipid antibodies and thrombosis in hospitalized patients].
Autorzy :
Shi XM; Department of Clinical Laboratory,Peking University First Hospital, Beijing 100034, China.
Gong Y; Department of Clinical Laboratory,Peking University First Hospital, Beijing 100034, China.
Hu XD; Department of Clinical Laboratory,Peking University First Hospital, Beijing 100034, China.
Zhai L; Department of Clinical Laboratory,Peking University First Hospital, Beijing 100034, China.
Pokaż więcej
Źródło :
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] [Zhonghua Yu Fang Yi Xue Za Zhi] 2021 Sep 06; Vol. 55 (9), pp. 1100-1104.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Anticardiolipin*
Thrombosis*
Adult ; Antibodies, Antiphospholipid ; Case-Control Studies ; Female ; Humans ; Immunoglobulin G ; Male ; Middle Aged ; beta 2-Glycoprotein I
Czasopismo naukowe
Tytuł :
Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial.
Autorzy :
Lachmann HJ; University College London Division of Medicine and Royal Free Hospital, London, UK. .
Lauwerys B; Department of Rheumatology, Cliniques Universitaires Saint-Luc & Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Miettunen P; Department of Paediatric Rheumatology, Alberta Children's Hospital, Calgary, Canada.
Kallinich T; Department of Pneumology and Immunology, Charité Medical University of Berlin, Germany.
Jansson A; Department of Rheumatology and Immunology, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.
Rosner I; Department of Rheumatology, Bnai Zion Medical Center, Haifa, Israel.
Manna R; Department of Internal Medicine and Autoinflammatory Diseases, Fondazione Policlinico Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Murias S; Paediatric Rheumatology Unit, University Hospital La Paz, Madrid, Spain.
Savic S; Department of Clinical Immunology and Allergy, St James's University Hospital, Leeds, and Musculoskelatal Biomedical Research Unit, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.
Smeets S; Immunology, Hepatology and Dermatology Franchise, Novartis Pharma B.V., Arnhem, the Netherlands.
De Benedetti F; Division of Rheumatology, Ospedale Pediatrico Bambino Gesú, Rome, Italy.
Simon A; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2021 Sep-Oct; Vol. 39 Suppl 132 (5), pp. 51-58. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antibodies, Monoclonal*/therapeutic use
Quality of Life*
Adult ; Antibodies, Monoclonal, Humanized ; Child ; Humans ; Patient Reported Outcome Measures ; Syndrome
Czasopismo naukowe
Tytuł :
Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making.
Autorzy :
Mason JA; Queensland Haemophilia Centre, Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Australia.; Little Red Drop Haematology, The Wesley Hospital, Brisbane, Australia.; University of Queensland, Brisbane, Australia.
Young G; Children's Hospital Los Angeles, Los Angeles, California, USA.; University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Sep; Vol. 27 (5), pp. 724-729. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Bispecific*
Hemophilia A*/drug therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Child ; Half-Life ; Humans ; Infant ; Infant, Newborn
Czasopismo naukowe
Tytuł :
Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy.
Autorzy :
Frota NF; Research Group on Protein Engineering and Health Solutions (GEPeSS), Fundação Oswaldo Cruz Ceará (Fiocruz-CE), São José, Precabura, 61760000, Eusébio, Ceara, Brazil; Federal University of Ceara (UFC), Campus do Pici (Bloco 873), 60440-970, Fortaleza, Ceara Brazil.
Rebouças AS; Research Group on Protein Engineering and Health Solutions (GEPeSS), Fundação Oswaldo Cruz Ceará (Fiocruz-CE), São José, Precabura, 61760000, Eusébio, Ceara, Brazil; Federal University of Ceara (UFC), Campus do Pici (Bloco 873), 60440-970, Fortaleza, Ceara Brazil.
Fuzo CA; Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Lourenzoni MR; Research Group on Protein Engineering and Health Solutions (GEPeSS), Fundação Oswaldo Cruz Ceará (Fiocruz-CE), São José, Precabura, 61760000, Eusébio, Ceara, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular graphics & modelling [J Mol Graph Model] 2021 Sep; Vol. 107, pp. 107949. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Single-Chain Antibodies*
Alemtuzumab ; Antibodies, Monoclonal, Humanized ; Antigens, CD ; Antigens, Neoplasm ; CD52 Antigen ; Glycoproteins ; Molecular Dynamics Simulation
Czasopismo naukowe
Tytuł :
Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays.
Autorzy :
Kizilocak H; Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, California, USA.
Marquez-Casas E; Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, California, USA.
Malvar J; Children's Hospital Los Angeles, Cancer and Blood Disease Institute, Los Angeles, California, USA.
Carmona R; Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, California, USA.
Young G; Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, California, USA.; Children's Hospital Los Angeles, Cancer and Blood Disease Institute, Los Angeles, California, USA.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2021 Sep; Vol. 27 (5), pp. 730-735. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Bispecific*/therapeutic use
Hemophilia A*/drug therapy
Antibodies, Monoclonal, Humanized ; Factor VIII ; Hemostasis ; Humans
Czasopismo naukowe
Tytuł :
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.
Autorzy :
Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA. Electronic address: .
Garfall AL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
van de Donk NWCJ; Amsterdam University Medical Center, VU University Medical Center, Amsterdam, Netherlands.
Nahi H; Karolinska University Hospital at Huddinge, Stockholm, Sweden.
San-Miguel JF; Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.
Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
Rosinol L; Institute of Hematology and Oncology, Hematology Department, IDIBAPS Hospital Clínic University of Barcelona, Barcelona, Spain.
Chari A; Mount Sinai School of Medicine, New York, NY, USA.
Bhutani M; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
Karlin L; Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
Benboubker L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire, Tours, France.
Pei L; Janssen Research & Development, Spring House, PA, USA.
Verona R; Janssen Research & Development, Spring House, PA, USA.
Girgis S; Janssen Research & Development, Spring House, PA, USA.
Stephenson T; Janssen Research & Development, Spring House, PA, USA.
Elsayed Y; Janssen Research & Development, Spring House, PA, USA.
Infante J; Janssen Research & Development, Spring House, PA, USA.
Goldberg JD; Janssen Research & Development, Spring House, PA, USA.
Banerjee A; Janssen Research & Development, Spring House, PA, USA.
Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain.
Krishnan A; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Aug 21; Vol. 398 (10301), pp. 665-674. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji :
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Bispecific*/pharmacology
Antineoplastic Agents, Immunological/*therapeutic use
B-Cell Maturation Antigen/*therapeutic use
Multiple Myeloma/*drug therapy
Administration, Intravenous ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; B-Cell Maturation Antigen/immunology ; Dose-Response Relationship, Drug ; Female ; Humans ; Injections, Subcutaneous ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; T-Lymphocytes/drug effects ; T-Lymphocytes/immunology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting.
Autorzy :
De Matteis E; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy.
Affaitati G; Department of Medicine and Science of Aging, 'G. D'Annunzio' University, Chieti, Italy.
Frattale I; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy.
Caponnetto V; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy.
Pistoia F; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy.
Giamberardino MA; Department of Medicine and Science of Aging, 'G. D'Annunzio' University, Chieti, Italy.
Sacco S; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy. .
Ornello R; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy.
Pokaż więcej
Źródło :
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 Aug; Vol. 42 (8), pp. 3297-3303. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antibodies, Monoclonal, Humanized*
Migraine Disorders*/drug therapy
Antibodies, Monoclonal/therapeutic use ; Calcitonin Gene-Related Peptide Receptor Antagonists ; Humans
Czasopismo naukowe
Tytuł :
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient.
Autorzy :
Harroche A; Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Sefiane T; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre.
Desvages M; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre, France; Laboratoire d'hématologie, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Borgel D; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre, France; Laboratoire d'hématologie, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Lasne D; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre, France; Laboratoire d'hématologie, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Casari C; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre.
Peyron I; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre.
Frenzel L; Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Chhun S; Laboratoire d'immunologie biologique, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Lenting PJ; Laboratory for Hemostasis, Inflammation and Thrombosis, Unité Mixed de Recherche 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94276 Le Kremlin-Bicêtre. .
Bally C; Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, 149, Rue de Sèvres, 75015 Paris.
Pokaż więcej
Źródło :
Haematologica [Haematologica] 2021 Aug 01; Vol. 106 (8), pp. 2287-2290. Date of Electronic Publication: 2021 Aug 01.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Bispecific*/therapeutic use
Hemophilia A*/drug therapy
Antibodies, Monoclonal, Humanized ; Factor VIII ; Humans ; Kinetics
Czasopismo naukowe
Tytuł :
Monoclonal Antibodies During Breastfeeding.
Autorzy :
Anderson PO; Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.
Pokaż więcej
Źródło :
Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine [Breastfeed Med] 2021 Aug; Vol. 16 (8), pp. 591-593. Date of Electronic Publication: 2021 May 05.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal*
Breast Feeding*
Antibodies, Monoclonal, Humanized ; Female ; Humans
Czasopismo naukowe
Tytuł :
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.
Autorzy :
Tré-Hardy M; Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium; Faculty of Medicine, Université libre de bruxelles, Brussels, Belgium; Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Belgium. Electronic address: .
Cupaiolo R; Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Papleux E; Department of Pneumology, Iris Hospitals South, Brussels, Belgium.
Wilmet A; Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Horeanga A; Department of Infectious Diseases, Iris Hospitals South, Brussels, Belgium.
Antoine-Moussiaux T; Department of Infectious Diseases, Iris Hospitals South, Brussels, Belgium.
Della Vecchia A; Department of Infectious Diseases, Iris Hospitals South, Brussels, Belgium.
Beukinga I; Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Vekemans M; Department of Infectious Diseases, Iris Hospitals South, Brussels, Belgium.
Blairon L; Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium.
Pokaż więcej
Źródło :
The Journal of infection [J Infect] 2021 Aug; Vol. 83 (2), pp. 237-279. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Letter; Comment
MeSH Terms :
Antibodies, Neutralizing*
Antibody Formation*
Antibodies, Viral ; Health Personnel ; Humans ; RNA, Messenger
Opinia redakcyjna
Tytuł :
Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b.
Autorzy :
Chan LJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.
Gandhirajan A; Centre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Carias LL; Centre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
Dietrich MH; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Vadas O; Department Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.; Proteins and Peptides Core Facility, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Visentin R; Department Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.; Proteins and Peptides Core Facility, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
França CT; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.
Menant S; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Soldati-Favre D; Department Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.
Mueller I; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia.
King CL; Centre for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA. .; Veteran Affairs Research Service, VA Medical Center, Cleveland, OH, USA. .
Tham WH; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. .; Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 09; Vol. 12 (1), pp. 1538. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Blocking*
Antibodies, Monoclonal/*immunology
Membrane Proteins/*metabolism
Plasmodium vivax/*metabolism
Protozoan Proteins/*metabolism
Reticulocytes/*metabolism
Antibodies, Protozoan/immunology ; Antigens, CD ; Antigens, Protozoan/chemistry ; Antigens, Protozoan/genetics ; Antigens, Protozoan/immunology ; Cambodia ; Crystallography, X-Ray ; Humans ; Longitudinal Studies ; Malaria, Vivax/immunology ; Malaria, Vivax/parasitology ; Membrane Proteins/chemistry ; Membrane Proteins/genetics ; Models, Molecular ; Plasmodium vivax/genetics ; Protozoan Proteins/chemistry ; Protozoan Proteins/genetics ; Receptors, Transferrin
Czasopismo naukowe
Tytuł :
Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody.
Autorzy :
Schiller ZA; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Rudolph MJ; New York Structural Biology Center, New York, New York, USA.
Toomey JR; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Ejemel M; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
LaRochelle A; Biomere, Worcester, Massachusetts, USA.
Davis SA; New York Structural Biology Center, New York, New York, USA.
Lambert HS; Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences Center, Covington, Louisiana, USA.
Kern A; Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, USA.
Tardo AC; Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences Center, Covington, Louisiana, USA.
Souders CA; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Peterson E; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Cannon RD; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Ganesa C; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Fazio F; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Mantis NJ; Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Cavacini LA; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Sullivan-Bolyai J; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Hu LT; Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, USA.
Embers ME; Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Tulane University Health Sciences Center, Covington, Louisiana, USA.
Klempner MS; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Wang Y; MassBiologics of the University of Massachusetts Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Jun 01; Vol. 131 (11).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Antibodies, Bacterial*/genetics
Antibodies, Bacterial*/immunology
Antibodies, Bacterial*/pharmacology
Borrelia burgdorferi*/genetics
Borrelia burgdorferi*/immunology
Lyme Disease*/drug therapy
Lyme Disease*/genetics
Lyme Disease*/immunology
Lyme Disease*/transmission
Antibodies, Monoclonal/*pharmacology
Amino Acid Substitution ; Animals ; Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/immunology ; Antigens, Surface/genetics ; Antigens, Surface/immunology ; Bacterial Outer Membrane Proteins/genetics ; Bacterial Outer Membrane Proteins/immunology ; Bacterial Vaccines/genetics ; Bacterial Vaccines/immunology ; Disease Models, Animal ; Humans ; Lipoproteins/genetics ; Lipoproteins/immunology ; Macaca fascicularis ; Macaca mulatta ; Male ; Mice ; Mice, Transgenic ; Mutation, Missense ; Ticks/immunology ; Ticks/microbiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies